SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Human Genome Sciences, Inc. (HGSI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: guy leung who wrote (16)8/13/1996 5:37:00 AM
From: Joseph wang   of 1127
 
To comment on your message and the message before that:

HGSI's contracts are expiring and they must look to renew their
agreements.

HGSI also is looking for a long term return (big dollars) on
producing drugs or getting royalties for drugs. Don't expect too
much from them near term. I think they are in a major R&D stage
which will suck up alot of their profits...despite revenue growth
and continuing strength (as seen in the quarter earnings report).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News